- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 195 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 188 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 220 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2024
- 144 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 92 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 272 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- October 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- February 2025
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2024
- 145 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- October 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- July 2024
- 153 Pages
Global
From €4056EUR$4,250USD£3,398GBP

The Automated Insulin Delivery (AID) market is a subset of the larger diabetes devices market. AID systems are designed to help people with diabetes manage their condition by automatically delivering insulin to the body. These systems are typically composed of an insulin pump, a continuous glucose monitor (CGM), and a control algorithm. The CGM measures glucose levels in the body and sends the data to the control algorithm, which then calculates the amount of insulin needed and sends a signal to the insulin pump to deliver the appropriate dose.
AID systems are designed to provide more accurate and consistent insulin delivery than traditional methods, and can help reduce the risk of hypoglycemia and other diabetes-related complications. They are also designed to be user-friendly and provide users with more control over their diabetes management.
Some companies in the AID market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, and Senseonics. Show Less Read more